Kennondale Capital Management LLC

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 2055199 RICHMOND, VA

Position in IKT

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,148,945

New position

Shares Held

565,983

first reported quarter

Ownership

0.406%

of shares outstanding

% of Portfolio

0.77%

of 13F equity value

Holder Rank

#26

of 105 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Kennondale Capital Management LLC holds $3,256,678 across 3 Biotechnology names. IKT ranks #2 (35.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	318,188	$1,323,662
2	IKT	Inhibikase Therapeutics, Inc. This page	565,983	$1,148,945
3	BHVN	Biohaven Ltd.	52,693	$784,071

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,148,945	565,983	—	Shares	Sole	2026-08-11
No filing history on record for this holder in this stock.